Carisma Therapeutics, Inc.

NasdaqGM:CARM 株式レポート

時価総額:US$35.4m

Carisma Therapeutics マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Steve Kelly

最高経営責任者

US$3.5m

報酬総額

CEO給与比率13.2%
CEO在任期間1.7yrs
CEOの所有権n/a
経営陣の平均在職期間1.5yrs
取締役会の平均在任期間1.7yrs

経営陣の近況

Recent updates

Companies Like Carisma Therapeutics (NASDAQ:CARM) Could Be Quite Risky

Sep 02
Companies Like Carisma Therapeutics (NASDAQ:CARM) Could Be Quite Risky

US$8.40: That's What Analysts Think Carisma Therapeutics, Inc. (NASDAQ:CARM) Is Worth After Its Latest Results

May 12
US$8.40: That's What Analysts Think Carisma Therapeutics, Inc. (NASDAQ:CARM) Is Worth After Its Latest Results

Investors Don't See Light At End Of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Tunnel And Push Stock Down 26%

Apr 19
Investors Don't See Light At End Of Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Tunnel And Push Stock Down 26%

We're A Little Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Rate

Mar 26
We're A Little Worried About Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Rate

Lacklustre Performance Is Driving Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 26% Price Drop

Jan 21
Lacklustre Performance Is Driving Carisma Therapeutics, Inc.'s (NASDAQ:CARM) 26% Price Drop

The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 27%

Dec 07
The Market Doesn't Like What It Sees From Carisma Therapeutics, Inc.'s (NASDAQ:CARM) Revenues Yet As Shares Tumble 27%

Analyst Forecasts Just Became More Bearish On Carisma Therapeutics, Inc. (NASDAQ:CARM)

Nov 12
Analyst Forecasts Just Became More Bearish On Carisma Therapeutics, Inc. (NASDAQ:CARM)

Here's Why We're Watching Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation

Oct 05
Here's Why We're Watching Carisma Therapeutics' (NASDAQ:CARM) Cash Burn Situation

We're Hopeful That Carisma Therapeutics (NASDAQ:CARM) Will Use Its Cash Wisely

Jun 15
We're Hopeful That Carisma Therapeutics (NASDAQ:CARM) Will Use Its Cash Wisely

CEO報酬分析

Carisma Therapeutics の収益と比較して、Steve Kelly の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$64m

Jun 30 2024n/an/a

-US$73m

Mar 31 2024n/an/a

-US$81m

Dec 31 2023US$4mUS$461k

-US$87m

Sep 30 2023n/an/a

-US$83m

Jun 30 2023n/an/a

-US$80m

Mar 31 2023n/an/a

-US$75m

Dec 31 2022US$666kUS$440k

-US$61m

Sep 30 2022n/an/a

-US$57m

Jun 30 2022n/an/a

-US$49m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$1mUS$416k

-US$41m

報酬と市場: Steveの 総報酬 ($USD 3.50M ) は、 US市場 ($USD 650.80K ) の同規模の企業の平均を上回っています。

報酬と収益: Steveの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Steve Kelly (59 yo)

1.7yrs

在職期間

US$3,504,425

報酬

Mr. Steven Kelly, also known as Steve, is President, Chief Executive Officer and Director of Carisma Therapeutics, Inc. He served as President, Chief Executive Officer and Director of CARISMA Therapeutics...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Steven Kelly
President1.7yrsUS$3.50mデータなし
Michael Klichinsky
Co-Founder & Chief Scientific Officer1.7yrsUS$1.60m1.16%
$ 410.6k
Richard Morris
CFO, Chief Compliance Officer1.7yrsUS$1.66m0%
$ 0
Saar Gill
Co-Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
Eric Siegel
General Counsel & Corporate Secretary1.4yrsデータなしデータなし
Terry Shields
Senior Vice President of Human Resources1.4yrsデータなしデータなし
Tom Wilton
Chief Business Officer4.8yrsデータなしデータなし
Eugene Kennedy
Chief Medical Officerless than a yearデータなしデータなし
Kenneth Locke
Senior Vice President of Technical Operationsless than a yearデータなしデータなし

1.5yrs

平均在職期間

52.5yo

平均年齢

経験豊富な経営陣: CARMの経営陣は 経験豊富 とはみなされません ( 1.5年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Steven Kelly
President1.7yrsUS$3.50mデータなし
Saar Gill
Co-Founder & Chairman of Scientific Advisory Boardno dataデータなしデータなし
Sanford Zweifach
Independent Chairman of the Board1.7yrsUS$271.55k0.00099%
$ 350.4
Hyam Levitsky
Member of Scientific Advisory Boardno dataデータなしデータなし
Carl June
Member of Scientific Advisory Boardno dataデータなしデータなし
Nina Bhardwaj
Member of Scientific Advisory Board4.3yrsデータなしデータなし
Briggs W. Morrison
Independent Director1.7yrsUS$220.20k0.029%
$ 10.3k
Marella Thorell
Directorless than a yearデータなしデータなし
John Hohneker
Independent Directorless than a yearデータなし0%
$ 0
Lisa Coussens
Member of Scientific Advisory Boardno dataデータなしデータなし
Prasad Adusumilli
Member of Scientific Advisory Board4.3yrsデータなしデータなし
Lin Guey
Member of Scientific Advisory Board1.8yrsデータなしデータなし

1.7yrs

平均在職期間

64yo

平均年齢

経験豊富なボード: CARMの 取締役会経験豊富 ではない ( 1.7年の平均在任期間) ため、新しい取締役会が必要であると考えられます。